Rezolute (RZLT) PT Raised to $15 at Citizens Post Positive FDA Feedback on cHI Ph3 Data

October 6, 2026 5:37 AM

Citizens analyst Jason Butler raised the price target on Rezolute (NASDAQ: RZLT) to $15.00 (from $11.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found